41

Amy Dockser Marcus, Author of "We the Scientists" (part 2)

We the Scientists: How a Daring Team of Parents and Doctors Forged a New Path for Medicine

LISTEN NOW
40

Amy Dockser Marcus, Author of "We the Scientists" (part 1)

We the Scientists: How a Daring Team of Parents and Doctors Forged A New Path for Medicine

LISTEN NOW
39

Sandra Bond Chapman, PhD and the Importance of Lifelong Brain Health (part 2)

Want to improve your brain’s performance? Find out the latest from Dr.

LISTEN NOW
38

Sandra Bond Chapman Ph.D. and the Importance of Lifelong Brain Health - Part 1

Want to improve your brain’s performance? Why not? You’re using it anyway. Find out the latest from Dr.

LISTEN NOW
37

Rebecca Chopp, Ph.D., and Her Unexpected Alzheimer’s Diagnosis (part 2)

Rebecca Chopp, Ph.D., built a life around a profession that prized the mind and then was unexpectedly diagnosed with Alzheimer's disease. Dr.

LISTEN NOW
36

Rebecca Chopp, Ph.D., and Her Unexpected Alzheimer’s Diagnosis (part 1)

Rebecca Chopp, Ph.D., built a life around a profession that prized the mind and then was unexpectedly diagnosed with Alzheimer's disease.

LISTEN NOW
35

Dr. Rudy Tanzi -The Latest on Alzheimer's Drugs (part 2)

BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi, Vice-Chair of Neurology at Massachusetts General Hospital, Co-Director of the McCance Center for Brain Health and Professor at Harvard Medical School.
LISTEN NOW
34

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

Will 2023 be a boom or bust year for new Alzheimer’s drugs? 

LISTEN NOW
33

George Vradenburg – The Future of Alzheimer’s Advocacy Part 2

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowi

LISTEN NOW
32

George Vradenburg and the Future of Alzheimer's Advocacy - Part 1

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowi

LISTEN NOW